Protocol Library
Each card lists peptide research notes — vial size, example research dose range, reconstitution example, frequency example, cycle length example, and risk level. All entries are educational. Not medical advice.
5-Amino-1MQ
low riskResearched as an NNMT inhibitor in metabolic studies.
- Vial
- 50 mg
- Dose
- 50–150 mg daily (research literature, oral)
- Freq
- Once daily (research example)
- Cycle
- 4–8 weeks (research example)
AICAR
high riskUsed in research contexts to study AMPK pathway activation, mitochondrial biogenesis and substrate utilization.
- Vial
- 50 mg lyophilized vial
- Dose
- Research literature ranges vary widely; educational example only.
- Freq
- Protocol-dependent in research.
- Cycle
- Short cycles in published research designs.
Bioglutide (NA-931)
moderate riskStudied in research contexts for incretin pathway activity and metabolic markers.
- Vial
- 5 mg lyophilized vial
- Dose
- Educational research dose example only.
- Freq
- Weekly in research designs.
- Cycle
- Multi-week educational examples.
Cagrilintide
moderate riskResearched for amylin receptor activity, gastric emptying and satiety endpoints.
- Vial
- 5 mg lyophilized vial
- Dose
- Commonly discussed research range: 0.3–2.4 mg weekly.
- Freq
- Weekly.
- Cycle
- 12–20 week educational example.
L-Carnitine
low riskStudied for its role in fatty-acid transport, mitochondrial metabolism, endurance research and metabolic energy research.
- Vial
- 200 mg/ml ampoule
- Dose
- Published research literature references a broad range; commonly cited examples include 500–2000 mg per research day.
- Freq
- Often daily in research scheduling examples.
- Cycle
- Continuous research periods are common.
Lipo-C
low riskStudied for hepatic lipid metabolism research contexts.
- Vial
- Multi-dose vial (varies)
- Dose
- Educational research range varies by formulation.
- Freq
- Weekly research administration example.
- Cycle
- 4–12 week educational example.
Mazdutide
moderate riskInvestigated for combined GLP-1 and glucagon receptor activity on metabolic endpoints.
- Vial
- 5 mg lyophilized vial
- Dose
- Commonly discussed research range: 1.5–9 mg weekly.
- Freq
- Weekly.
- Cycle
- 12–24 week educational example.
MOTS-c
low riskResearched in mitochondrial and metabolic regulation contexts.
- Vial
- 10 mg
- Dose
- 5–10 mg weekly (research literature)
- Freq
- 2–3x weekly (research example)
- Cycle
- 4–8 weeks (research example)
NAD+
moderate riskResearched in NAD+ metabolism and cellular energy contexts.
- Vial
- 500 mg
- Dose
- 100–500 mg per use (research literature)
- Freq
- 1–3x weekly (research example)
- Cycle
- 4–8 weeks (research example)
Retatrutide
moderate riskResearched as a triple receptor agonist for metabolic and bodyweight studies.
- Vial
- 10 mg
- Dose
- 1 mg – 12 mg weekly (research literature)
- Freq
- Once weekly (research example)
- Cycle
- 12+ weeks (research example)
Semaglutide
moderate riskCommonly researched in studies of appetite regulation, satiety, and glucose metabolism.
- Vial
- 5 mg
- Dose
- 0.25 mg – 2.4 mg weekly (research literature)
- Freq
- Once weekly (research example)
- Cycle
- 12+ weeks (research example)
SS-31 (Elamipretide)
moderate riskResearched in mitochondrial cardiolipin and energy production contexts.
- Vial
- 10 mg
- Dose
- 1–5 mg daily (research literature)
- Freq
- Once daily (research example)
- Cycle
- 4–8 weeks (research example)
Survodutide
moderate riskInvestigated for combined incretin and glucagon receptor activity.
- Vial
- 5 mg lyophilized vial
- Dose
- Commonly discussed research range: 0.3–4.8 mg weekly.
- Freq
- Weekly.
- Cycle
- 12–24 week educational example.
Tirzepatide
moderate riskStudied for dual GIP/GLP-1 receptor activity in metabolic research contexts.
- Vial
- 10 mg
- Dose
- 2.5 mg – 15 mg weekly (research literature)
- Freq
- Once weekly (research example)
- Cycle
- 12+ weeks (research example)
Looking for a research supplier?
Enhanced Performance is a separate research supply platform. Visiting or purchasing is optional and not required to use PepToolbox.
Disclosure: Enhanced Performance is a separate platform connected to the owner of this website. Purchasing is optional and not required to use this tool.